Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2004 Dec 10;7(5):121–126. doi: 10.1016/0167-5699(86)90072-1

Genetic and molecular aspects of demyelination

Nicholas K Gonatas a, Mark I Greene b, Byron H Waksman c
PMCID: PMC7133909  PMID: 25289996

Abstract

Three groups of investigators came together to learn from each other in a workshop: neurologists and neuropathologists interested in the pathogenesis of multiple sclerosis (MS) and other demyelinative diseases of man and similar autoimmune and virus-induced model diseases in animals; immunologists and virologists concerned with the genetic controls found to play a role in these diseases; and geneticists and molecular biologists investigating specific gene products and their role in recognition function and cell interactions in model immunological systems.

References

  • 1.Sibley W.A., Bamford C.R., Clark K. Lancet. 1985;i:1313–1315. doi: 10.1016/S0140-6736(85)92801-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Fritz R.B., Keen M.J.S., Chou C.-H.J. J. Immunol. 1985;134:1–5. [Google Scholar]
  • 3.Koprowski H., DeFreitas E.C., Harper M.E. Nature (London) 1985;318:154–160. doi: 10.1038/318154a0. [DOI] [PubMed] [Google Scholar]
  • 4.Narayan O., Griffin D.E., Silverstein A.M. J. Infect. Dis. 1977;135:800–806. doi: 10.1093/infdis/135.5.800. [DOI] [PubMed] [Google Scholar]
  • 5.Lyman W.D., Brosnan C.F., Raine C.S. J. Neuroimmunol. 1985;7:345–353. [PubMed] [Google Scholar]
  • 6.Waldor M.K., Sriram S., Hardy R. Science. 1985;227:415–417. doi: 10.1126/science.3155574. [DOI] [PubMed] [Google Scholar]
  • 7.Brostoff S.W., Mason D.W. J. Immunol. 1984;133:1938–1942. [PubMed] [Google Scholar]

Articles from Immunology Today are provided here courtesy of Elsevier

RESOURCES